Iorga B., Neacsu C.D., Neiss W.F., Wagener R., Paulsson M., Stehle R., Pfitzer G. Micromechanical function of myofibrils isolated from skeletal and cardiac muscles of the zebrafish. The Journal of General Physiology, p.255, 2011.

Goldsmith DJ, Covic A. Blood pressure in dialysis patients-look before we leap.. Lancet, p.1945-6. , 2009.

Vitale K, Dzakula A, Suljiæ P, Todoroviæ G, Vuletiæ S, Coviæ A. Who empowers women towards healthier lifestyles? Example from western Croatia.. Coll Antropol., p.165-70., 2009.

Dede F, Yildiz;ld Ayli D; Colak N, Odabaş AR, Akoglu H, Eskioglu E, Covic A Modulation of the immune response to HBV vaccination by hemodialysis membranes.. Int Urol Nephrol., p.1069-75, 2010.

Kanbay M, Turgut F, Covic A, Goldsmith D Statin treatment for dyslipidemia in chronic kidney disease and renal transplantation: a review of the evidence.. J Nephrol, p.598-609, 2009.

Locatelli F, Covic A, Macdougall IC, Scherhag A, Wiecek A; ORAMA Study Group. Effect of computer-assisted European Best Practice Guideline implementation on adherence and target attainment: ORAMA results.. J Nephrol., p.662-74., 2009.

Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent- resistant anemia in dialysis patients: review of causes and management.. Blood Purif., p.1-12., 2010.

Goldsmith D, Covic AC. Jupiter or Aurora? Micro-inflammation and dyslipidaemia: twin targets for statin therapy in CKD.. Int Urol Nephrol., p.133-6., 2010.

Covic A, Gusbeth-Tatomir P. The role of the renin-angiotensin-aldosterone system in renal artery stenosis, renovascular hypertension, and ischemic nephropathy: diagnostic implications.. Prog Cardiovasc Dis, p.204-8., 2009.

Kanbay M, Afsar B, Gusbeth-Tatomir P, Covic A. Arterial stiffness in dialysis patients: where are we now?. Int Urol Nephrol., p.741-52., 2010.

Goldsmith D, Covic A. Blood pressure control in CKD stage 5D patients–are we more or less certain what to do in 2009?. Nephrol Dial Transplant, p.3597-601, 2009.

Duranay M, Kanbay M, Akay H, Unverdi S, Sürer H, Altay M, Kirbaş I, Covic A, Zoccali C. Nebivolol improves renal function in patients who underwent angioplasty due to renal artery stenosis: a pilot study.. Nephron Clin Pract., p.c213-7., 2010.

Voroneanu L, Covic A. Arrhythmias in hemodialysis patients.. J Nephrol., p.716-25, 2009.

Kanbay M, Goldsmith D, Uyar ME, Turgut F, Covic A. Magnesium in chronic kidney disease: challenges and opportunities.. Blood Purif., p.280-92., 2010.

Schiller A, Covic A Kidney and brain–a renal perspective of ‘Les Liaisons Dangereuses’.. Nephrol Dial Transplant., p.1370-3, 2010.

Covic A, Mircescu G. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.. Nephrol Dial Transplant., p.2722-30, 2010.

Panduru NM, Cimponeriu D, Cruce M, Ion DA, Moţa E, Moţa M, Serafinceanu C, Chivu LI, Panduru M, Chivu RD, Covic AC. Association of +35A/C (intron3/exon3) polymorphism in SOD1-gene with diabetic nephropathy in type 1 diabetes.. Rom J Morphol Embryol., p.37-41, 2010.

Busuioc M, Gusbeth-Tatomir P, Covic A. Acute renal failure–the present and perspectives].. Rev Med Chir Soc Med Nat Iasi, p.984-90., 2009.

Cepoi V, Covic A, Volovãţ C. Clinical epidemiologic assessment of the incidence of chronic kidney diseases registered in Romania, Iaşi County, in the years of 2004-2008].. Rev Med Chir Soc Med Nat Iasi, p.984-90, 2009.

Goldsmith D, Covic A. Time to Reconsider Evidence for Anaemia Treatment (TREAT) = Essential Safety Arguments (ESA).. Nephrol Dial Transplant, p.2052-62, 2010.

van Biesen W, Heimburger O, Krediet R, Rippe B, La Milia V, Covic A, Vanholder R; ERBP working group on peritoneal dialysis. Evaluation of peritoneal membrane characteristics: clinical advice for prescription management by the ERBP working group.. Nephrol Dial Transplant., p.2052-62. , 2010.

Segall L, Covic A. Diagnosis of tuberculosis in dialysis patients: current strategy.. Clin J Am Soc Nephrol, p.1114-22., 2010.

Covic A, Bammens B, Lobbedez T, Segall L, Heimbürger O, van Biesen W, Fouque D, Vanholder R. Educating end-stage renal disease patients on dialysis modality selection: clinical advice from the European Renal Best Practice (ERBP) Advisory Board.. Nephrol Dial Transplant., p.1757-9., 2010.

Segall L, Covic A. What to measure at dialysis initiation for reliable prediction of cardiovascular outcomes: just look at crp and pulse pressure.. Perit Dial Int. , p.280-3, 2010.

Covic A, Kanbay M, Voroneanu L, Turgut F, Serban DN, Serban IL, Goldsmith DJ. Vascular calcification in chronic kidney disease.. Clin Sci (Lond)., p.111-21, 2010.

Hogas SM, Voroneanu L, Serban DN, Segall L, Hogas MM, Serban IL, Covic A. Methods and potential biomarkers for the evaluation of endothelial dysfunction in chronic kidney disease: a critical approach.. J Am Soc Hypertens, p.116-27, 2010.

Voroneanu L, Cusai C, Hogas S, Ardeleanu S, Onofriescu M, Nistor I, Prisada O, Sascau R, Goldsmith D, Covic A. The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.. Int Urol Nephrol, p.789-97, 2010.

de Francisco AL, Leidig M, Covic AC, Ketteler M, Benedyk-Lorens E, Mircescu GM, Scholz C, Ponce P, Passlick-Deetjen J. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.. Nephrol Dial Transplant, p.3707-17, 2010.

Kanbay M, Nicoleta M, Selcoki Y, Ikizek M, Aydin M, Eryonucu B, Duranay M, Akcay A, Armutcu F, Covic A. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.. Clin J Am Soc Nephrol., p.1780-6., 2010.

Locatelli F, Aljama P, Canaud B, Covic A, De Francisco A, Macdougall IC, Wiecek A, Vanholder R; Anaemia Working Group of European Renal Best Practice (ERBP). Target haemoglobin to aim for with erythropoiesis-stimulating agents: a position statement by ERBP following publication of the Trial to reduce cardiovascular events with Aranesp therapy (TREAT) study.. Nephrol Dial Transplant., p.2846-50., 2010.

Covic A, Voroneanu L, Goldsmith D. The effects of vitamin D therapy on left ventricular structure and function – are these the underlying explanations for improved CKD patient survival?. Nephron Clin Pract., p.c187-95, 2010.

Ardeleanu S, Panaghiu L, Prisadã O, Sascãu R, Voroneanu L, Hogaş S, Mardare N, Covic A. Regression of left ventricular hypertrophy in hemodialyzed patients is possible: a follow-up study.. Int Urol Nephrol, 2010.

Kovesdy CP, Molnar MZ, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Szathmari M, Covic A, Keszei A, Beko G, Lakatos P, Kosa J, Mucsi I. Associations between serum leptin level and bone turnover in kidney transplant recipients.. Clin J Am Soc Nephrol., p.2297-304, 2010.

Molnar MZ, Mucsi I, Macdougall IC, Marsh JE, Yaqoob M, Main J, Courtney AE, Fogarty D, Mikhail A, Choukroun G, Short CD, Covic A, Goldsmith DJ. Prevalence and management of anaemia in renal transplant recipients: data from ten European centres.. Nephron Clin Pract, p.c127-34., 2010.

Kanbay M, Afsar B, Goldsmith D, Covic A. Sudden death in hemodialysis: an update.. Blood Purif. , p.135-45, 2010.

Goldsmith DJ, Covic A, Fouque D, Locatelli F, Olgaard K, Rodriguez M, Spasovski G, Urena P, Zoccali C, London GM, Vanholder R. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement.. Nephrol Dial Transplant. , p.3823-31, 2010.

Kanbay M, Sánchez-Lozada LG, Franco M, Madero M, Solak Y, Rodriguez-Iturbe B, Covic A, Johnson RJ Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin.. Nephrol Dial Transplant, p.430-7, 2011.

Covic A, Schiller A. Burden of disease – prevalence and incidence of ESRD in selected European regions and populations.. Clin Nephrol, p.S23-7., 2010.

Duranay M, Segall L, Sen N, Yilmaz FM, Cetin M, Isleyen A, Kanbay M, Covic A. Bone morphogenic protein-7 serum level decreases significantly in patients with contrast-induced nephropathy.. Int Urol Nephrol. , 2010.

Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A. Uric acid in hypertension and renal disease: the chicken or the egg?. Blood Purif., p.288-95, 2010.

Caskey FJ, Kramer A, Elliott RF, Stel VS, Covic A, Cusumano A, Geue C, Macleod AM, Zwinderman AH, Stengel B, Jager KJ. Global variation in renal replacement therapy for end-stage renal disease.. Nephrol Dial Transplant., 2011.

Cepoi V, Onofriescu M, Segall L, Covic A The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.. Int Urol Nephrol, 2011.

Kanbay A, Buyukoglan H, Ozdogan N, Kaya E, Oymak FS, Gulmez I, Demir R, Kokturk O, Covic A. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease.. Int Urol Nephrol., 2011.